Labcorp grows business outside of Covid-19 by 10% in first quarter with spin-off still on track for mid-2023


Labcorp appears to be refocusing its efforts away from Covid-19 as the world emerges from the pandemic, with its Q1 FY2023 financial results negatively impacted by the decrease in Covid-19 testing while it also grew its other business sectors.

Previous Holy Land Experience theme park demolition underway to prep for new AdventHealth ER
Next Rare bipartisan coalition in Texas House OKs reform of controversial affordable housing incentives